These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 7537556)
21. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells. Jayson GC; Gallagher JT Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592 [TBL] [Abstract][Full Text] [Related]
22. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499 [TBL] [Abstract][Full Text] [Related]
23. The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1. Angulo J; Ojeda R; de Paz JL; Lucas R; Nieto PM; Lozano RM; Redondo-Horcajo M; Giménez-Gallego G; Martín-Lomas M Chembiochem; 2004 Jan; 5(1):55-61. PubMed ID: 14695513 [TBL] [Abstract][Full Text] [Related]
24. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation. Krufka A; Guimond S; Rapraeger AC Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517 [TBL] [Abstract][Full Text] [Related]
25. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131 [TBL] [Abstract][Full Text] [Related]
26. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Coltrini D; Rusnati M; Zoppetti G; Oreste P; Grazioli G; Naggi A; Presta M Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421 [TBL] [Abstract][Full Text] [Related]
27. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857 [TBL] [Abstract][Full Text] [Related]
28. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186 [TBL] [Abstract][Full Text] [Related]
29. Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. Taylor KR; Rudisill JA; Gallo RL J Biol Chem; 2005 Feb; 280(7):5300-6. PubMed ID: 15563459 [TBL] [Abstract][Full Text] [Related]
30. Selective impairment of the synthesis of basic fibroblast growth factor binding domains of heparan sulphate in a COS cell mutant defective in N-sulphotransferase. Ishihara M; Guo Y; Swiedler SJ Glycobiology; 1993 Feb; 3(1):83-8. PubMed ID: 8448389 [TBL] [Abstract][Full Text] [Related]
31. Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2. Tabeur C; Mallet JM; Bono F; Herbert JM; Petitou M; Sinaÿ P Bioorg Med Chem; 1999 Sep; 7(9):2003-12. PubMed ID: 10530949 [TBL] [Abstract][Full Text] [Related]
32. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Fromm JR; Hileman RE; Weiler JM; Linhardt RJ Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372 [TBL] [Abstract][Full Text] [Related]
33. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Noti C; de Paz JL; Polito L; Seeberger PH Chemistry; 2006 Nov; 12(34):8664-86. PubMed ID: 17066397 [TBL] [Abstract][Full Text] [Related]
34. Nature of the interaction of heparin with acidic fibroblast growth factor. Mach H; Volkin DB; Burke CJ; Middaugh CR; Linhardt RJ; Fromm JR; Loganathan D; Mattsson L Biochemistry; 1993 May; 32(20):5480-9. PubMed ID: 7684608 [TBL] [Abstract][Full Text] [Related]